{"id":241132,"date":"2025-07-04T18:02:33","date_gmt":"2025-07-04T16:02:33","guid":{"rendered":"https:\/\/www.wholecelium.com\/?p=241132"},"modified":"2025-07-04T18:02:34","modified_gmt":"2025-07-04T16:02:34","slug":"magic-mushrooms-still-give-lasting-depression-relief-after-5-years","status":"publish","type":"post","link":"https:\/\/www.wholecelium.com\/pl\/blog\/magic-mushrooms-still-give-lasting-depression-relief-after-5-years\/","title":{"rendered":"Magic Mushrooms Still Give Lasting Depression Relief After 5 Years"},"content":{"rendered":"

A Single Dose of Psilocybin Shows Lasting Depression Relief After 5 Years: Here\u2019s Why That\u2019s So Exciting<\/strong><\/p>\n\n\n\n

In a landmark follow-up study presented at the Psychedelic Science 2025 conference, researchers revealed something remarkable: a single dose of psilocybin<\/strong>, the active ingredient in \u201cmagic mushrooms,\u201d may offer relief from depression that lasts not just weeks or months, but years<\/em>. In fact, 67% of patients were still in remission<\/strong> from clinical depression five years after their treatment.<\/p>\n\n\n\n

Let that sink in.<\/strong><\/p>\n\n\n\n

For people living with major depressive disorder (MDD)<\/em>, a condition that often resists traditional treatment and requires ongoing medication or therapy, this is a truly groundbreaking<\/em> finding. And while researchers and experts alike urge caution and continued study, the implications for the future of mental health care and psychedelic-assisted therapy are both promising and profound.<\/p>\n\n\n\n

A Look Back: The 2020 Breakthrough<\/h3>\n\n\n\n

This new study follows up on participants from a 2020 clinical trial (the first of its kind) <\/em>publikowany w JAMA Psychiatry<\/a><\/em>. That original study included 24 individuals diagnosed with major depressive disorder. Half received psilocybin-assisted therapy early in the trial, while the other half received it after an eight-week delay.<\/p>\n\n\n\n

In addition to the single psilocybin dose, each participant also engaged in 11 hours of supportive psychotherapy. The results, even one month after the treatment, were impressive: 17 of the 24 patients<\/strong> reported improvements in their depression symptoms. Even more encouraging, 14 of them were in full remission<\/strong>.<\/p>\n\n\n\n

As the researchers noted at the time, \u201cThe effectiveness of psilocybin therapy after a single or only a few administrations represents another substantial advantage over commonly used antidepressants that require daily administration.\u201d<\/em><\/p>\n\n\n\n

\"\"
przez Unsplash<\/mark><\/em><\/figcaption><\/figure>\n\n\n\n

In other words, this isn\u2019t just about symptom management. It\u2019s about the possibility<\/em> of long-term transformation.<\/p>\n\n\n\n

Fast Forward to 2025: How Are They Doing Now?<\/h4>\n\n\n\n

The follow-up study reconnected with 21 of those original participants, now five years post-treatment. And what they found is enough to turn heads in both psychiatry and psychedelic medicine:<\/p>\n\n\n\n